Sign In
NewsRadar


June 11 - 13, 2014
Hotel InterContinental Vienna
EVCA Symposium 2014
The EVCA Symposium is the event of the year for private equity’s stakeholders to look beyond day-to-day operations and exchange ideas that will shape the growth path of the industry. This is an unparalleled opportunity for private equity’s leaders to identify breakthrough strategies that will catapult the industry forward and solidify its position as a transforming economic force.



New Agenda Packed with Mission-Critical Content
The EVCA is dedicated to delivering the highest quality insight and analysis to propel the industry forward. As part of this commitment, this year’s Symposium will focus its content on bolstering the private equity industry’s position as a global influencer and change agent. Going beyond operational issues, this strategic program will hone in on the topics that will define the industry and impact economies for years to come:

Global Capital Markets: Mapping Out Certainty Amidst Change
Boosting Investor Appetite for Europe
Smart Cities, Smart Technology, Smart Society
Growth through Innovation & Entrepreneurship


More information about this event
Data


20,243
Tech investments
From our Online Data Service
13,061
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Jul 16€2.1MAudio/Video
Jul 16€1.5MWireless applications
Jul 15€10.0MConsumer electronics
Jul 15€10.1MInternet services
Jul 15€18.4MDatabase
Jul 15N/AInternet services
Jul 14€68.5MBusiness applications

For information on Europe's most extensive database on technology funding click here!

Events


BIO-Europe 2015

November 2 - 4, 2015 CONNECTIONS Europe

November 10 - 11, 2015

Press Releases


Jul 22
Wilson Therapeutics
wilson therapeutics announces the appointment of dr. carl bjartmar ...

Jul 16
Immunocore Ltd
immunocore secures $320 million (£205 million) in europe’s largest ...

Jul 15
Mailjet
iris capital leads series b round for email service provider mailjet

Jul 15
Credit Benchmark
credit benchmark raises $20m in series b financing led by balderton...

Jul 10
Autifony Therapeutics
autifony therapeutics extends series a with £8 million for hearing ...





About usContact usLegal Information
Copyright © 1999-2015
Emerging Technology Research Europe Inc. All rights reserved.